Hussain Mulla ☆ 2009-05-12 20:34 (5461 d 14:23 ago) Posting: # 3678 Views: 3,137 |
|
Dear All Please accept my apology in advance for asking a simple question, but I am not an expert in this field at all. If I am developing a new IR solution formulation for a drug which is BCS Class 1 or 3, and which has previously only been marketed as a IR solid oral dosage form, is it acceptable to apply for a biowaiver? All the regulatory documents I have looked at only talk about soild oral dosage forms. I look forward to hearing your replies. Sincerely Dr H. Mulla TEDIC Edit: Category changed. [Helmut] |